|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Katanoda K, Hori M, Matsuda T, Shibata A,
Nishino Y, Hattori M, Soda M, Ioka A, Sobue T and Nishimoto H: An
updated report on the trends in cancer incidence and mortality in
Japan, 1958–2013. Jpn J Clin Oncol. 45:390–401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mayer RJ, Venook AP and Schilsky RL:
Progress against GI cancer during the American Society of Clinical
Oncology's first 50 years. J Clin Oncol. 32:1521–1530. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brenner H, Kretschmann J, Stock C and
Hoffmeister M: Expected long-term impact of screening endoscopy on
colorectal cancer incidence: A modelling study. Oncotarget.
7:48168–48179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brenner H, Chang-Claude J, Seiler CM and
Hoffmeister M: Long-term risk of colorectal cancer after negative
colonoscopy. J Clin Oncol. 29:3761–3767. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Venook AP, Weiser MR and Tepper JE:
Colorectal cancer: All hands on deck. Am Soc Clin Oncol Educ Book.
1–89. 2014.
|
|
7
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Gramont A, Figer A, Seymour M, Homerin
M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freyer
G, et al: Leucovorin and fluorouracil with or without oxaliplatin
as first-line treatment in advanced colorectal cancer. J Clin
Oncol. 18:2938–2947. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Douillard JY, Cunningham D, Roth AD,
Navarro M, James RD, Karasek P, Jandik P, Iveson T, Carmichael J,
Alakl M, et al: Irinotecan combined with fluorouracil compared with
fluorouracil alone as first-line treatment for metastatic
colorectal cancer: A multicentre randomised trial. Lancet.
355:1041–1047. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goldberg RM, Sargent DJ, Morton RF, Fuchs
CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC and Alberts
SR: A randomized controlled trial of fluorouracil plus leucovorin,
irinotecan, and oxaliplatin combinations in patients with
previously untreated metastatic colorectal cancer. J Clin Oncol.
22:23–30. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tournigand C, André T, Achille E, Lledo G,
Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, et
al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced
colorectal cancer: A randomized GERCOR study. J Clin Oncol.
22:229–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pezzani L, Milani D, Manzoni F, Baccarin
M, Silipigni R, Guerneri S and Esposito S: HOXA genes cluster:
Clinical implications of the smallest deletion. Ital J Pediatr.
41:312015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Quinonez SC and Innis JW: Human HOX gene
disorders. Mol Genet Metab. 111:4–15. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Novak P, Jensen T, Oshiro MM, Wozniak RJ,
Nouzova M, Watts GS, Klimecki WT, Kim C and Futscher BW: Epigenetic
inactivation of the HOXA gene cluster in breast cancer. Cancer Res.
66:10664–10670. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Strathdee G, Holyoake TL, Sim A, Parker A,
Oscier DG, Melo JV, Meyer S, Eden T, Dickinson AM, Mountford JC, et
al: Inactivation of HOXA genes by hypermethylation in myeloid and
lymphoid malignancy is frequent and associated with poor prognosis.
Clin Cancer Res. 13:5048–5055. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bach C, Buhl S, Mueller D, García-Cuéllar
MP, Maethner E and Slany RK: Leukemogenic transformation by HOXA
cluster genes. Blood. 115:2910–2918. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen KN, Gu ZD, Ke Y, Li JY, Shi XT and Xu
GW: Expression of 11 HOX genes is deregulated in esophageal
squamous cell carcinoma. Clin Cancer Res. 11:1044–1049.
2005.PubMed/NCBI
|
|
18
|
Widschwendter M, Apostolidou S, Jones AA,
Fourkala EO, Arora R, Pearce CL, Frasco MA, Ayhan A, Zikan M,
Cibula D, et al: HOXA methylation in normal endometrium from
premenopausal women is associated with the presence of ovarian
cancer: A proof of principle study. Int J Cancer. 125:2214–2218.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Orlovsky K, Kalinkovich A, Rozovskaia T,
Shezen E, Itkin T, Alder H, Ozer HG, Carramusa L, Avigdor A,
Volinia S, et al: Down-regulation of homeobox genes MEIS1 and HOXA
in MLL-rearranged acute leukemia impairs engraftment and reduces
proliferation. Proc Natl Acad Sci USA. 108:pp. 7956–7961. 2011;
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kanai M, Hamada J, Takada M, Asano T,
Murakawa K, Takahashi Y, Murai T, Tada M, Miyamoto M, Kondo S and
Moriuchi T: Aberrant expressions of HOX genes in colorectal and
hepatocellular carcinomas. Oncol Rep. 23:843–851. 2010.PubMed/NCBI
|
|
21
|
Bhatlekar S, Addya S, Salunek M, Orr CR,
Surrey S, McKenzie S, Fields JZ and Boman BM: Identification of a
developmental gene expression signature, including HOX genes, for
the normal human colonic crypt stem cell niche: Overexpression of
the signature parallels stem cell overpopulation during colon
tumorigenesis. Stem Cells Dev. 23:167–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Union for International Cancer Control
(UICC), . TNM Classification of Malignant Tumors. Gospodarowicz MK,
Wittekind Ch and Sobin LH: 7th. Wiley-Blackwell; Oxford: 2009
|
|
23
|
Sobin LH and Compton CC: TNM seventh
edition: What's new, what's changed: Communication from the
International Union Against Cancer and the American Joint Committee
on Cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okano M, Kumamoto K, Saito M, Onozawa H,
Saito K, Abe N, Ohtake T and Takenoshita S: Upregulated Annexin A1
promotes cellular invasion in triple-negative breast cancer. Oncol
Rep. 33:1064–1070. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tachibana K, Saito M, Imai JI, Ito E,
Yanagisawa Y, Honma R, Saito K, Ando J, Momma T, Ohki S, et al:
Clinicopathological examination of dipeptidase 1 expression in
colorectal cancer. Biomed Rep. 6:423–428. 2017.PubMed/NCBI
|
|
26
|
Saito M, Shiraishi K, Matsumoto K,
Schetter AJ, Ogata-Kawata H, Tsuchiya N, Kunitoh H, Nokihara H,
Watanabe S, Tsuta K, et al: A three-microRNA signature predicts
responses to platinum-based doublet chemotherapy in patients with
lung adenocarcinoma. Clin Cancer Res. 20:4784–4793. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calvo R, West J, Franklin W, Erickson P,
Bemis L, Li E, Helfrich B, Bunn P, Roche J, Brambilla E, et al:
Altered HOX and WNT7A expression in human lung cancer. Proc Natl
Acad Sci USA. 97:pp. 12776–12781. 2000; View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shin SH, Kim BH, Jang JJ, Suh KS and Kang
GH: Identification of novel methylation markers in hepatocellular
carcinoma using a methylation array. J Korean Med Sci.
25:1152–1159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Beachy SH, Onozawa M, Silverman D, Chung
YJ, Rivera MM and Aplan PD: Isolated Hoxa9 overexpression
predisposes to the development of lymphoid but not myeloid
leukemia. Exp Hematol. 41:518–529.e5. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thorsteinsdottir U, Mamo A, Kroon E,
Jerome L, Bijl J, Lawrence HJ, Humphries K and Sauvageau G:
Overexpression of the myeloid leukemia-associated Hoxa9 gene in
bone marrow cells induces stem cell expansion. Blood. 99:121–129.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aine M, Sjödahl G, Eriksson P, Veerla S,
Lindgren D, Ringnér M and Höglund M: Integrative epigenomic
analysis of differential DNA methylation in urothelial carcinoma.
Genome Med. 7:232015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu SL, Lee DC, Sohn HA, Lee SY, Jeon HS,
Lee JH, Park CG, Lee HY, Yeom YI, Son JW, et al: Homeobox A9
directly targeted by miR-196b regulates aggressiveness through
nuclear Factor-kappa B activity in non-small cell lung cancer
cells. Mol Carcinog. 55:1915–1926. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
How C, Hui AB, Alajez NM, Shi W, Boutros
PC, Clarke BA, Yan R, Pintilie M, Fyles A, Hedley DW, et al:
MicroRNA-196b regulates the homeobox B7-vascular endothelial growth
factor axis in cervical cancer. PLoS One. 8:e678462013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Alvarado-Ruiz L, Martinez-Silva MG,
Torres-Reyes LA, Pina-Sanchez P, Ortiz-Lazareno P, Bravo-Cuellar A,
Aguilar-Lemarroy A and Jave-Suarez LF: HOXA9 is underexpressed in
cervical cancer cells and its restoration decreases proliferation,
migration and expression of epithelial-to-mesenchymal transition
genes. Asian Pac J Cancer Prev. 17:1037–1047. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Witkiewicz AK, McMillan EA, Balaji U, Baek
G, Lin WC, Mansour J, Mollaee M, Wagner KU, Koduru P, Yopp A, et
al: Whole-exome sequencing of pancreatic cancer defines genetic
diversity and therapeutic targets. Nat Commun. 6:67442015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cancer Genome Atlas Network, .
Comprehensive molecular characterization of human colon and rectal
cancer. Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hassan NM, Hamada J, Murai T, Seino A,
Takahashi Y, Tada M, Zhang X, Kashiwazaki H, Yamazaki Y, Inoue N
and Moriuchi T: Aberrant expression of HOX genes in oral dysplasia
and squamous cell carcinoma tissues. Oncol Res. 16:217–224. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Makiyama K, Hamada J, Takada M, Murakawa
K, Takahashi Y, Tada M, Tamoto E, Shindo G, Matsunaga A, Teramoto
K, et al: Aberrant expression of HOX genes in human invasive breast
carcinoma. Oncol Rep. 13:673–679. 2005.PubMed/NCBI
|
